Published 17 days ago • loading... • Updated 17 days agoShow Less IconStartup promising to scale custom CRISPR therapies abruptly scraps plans Summary by STATPersonalized gene-editing startup co-founded by Jennifer Doudna, facing stiff competition, IP hurdles and production issues, closes custom PKU drug program.Share menu1 Articles1 ArticlesAllLeftCenter1RightSearch IconSort IconSTATCenterFactualityOwnershipStartup promising to scale custom CRISPR therapies abruptly scraps plansPersonalized gene-editing startup co-founded by Jennifer Doudna, facing stiff competition, IP hurdles and production issues, closes custom PKU drug program.17 days ago·Boston, United StatesRead Full ArticleThink freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribeBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsCoverage DetailsTotal News Sources1Leaning Left0Leaning Right0Center1Last Updated16 days agoBias Distribution100% CenterBias Distribution Too Big Arrow IconToo Big Arrow IconCaret Up Icon100% of the sources are Center100% CenterC 100%Factuality Info IconTo view factuality data please Upgrade to PremiumOwnership Info IconTo view ownership data please Upgrade to VantageSTAT broke the news in Boston, United States 17 days ago on Tuesday, August 4, 2026.Too Big Arrow IconCaret Down IconSources are mostly out of (0)Similar News TopicsStartups Plus IconCRISPR Plus IconUnited States Plus IconShow AllBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsSimilar News TopicsStartups Plus IconCRISPR Plus IconUnited States Plus IconShow All